168 related articles for article (PubMed ID: 14668431)
1. Unstable mutants in the peripheral endosomal membrane component ALS2 cause early-onset motor neuron disease.
Yamanaka K; Vande Velde C; Eymard-Pierre E; Bertini E; Boespflug-Tanguy O; Cleveland DW
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):16041-6. PubMed ID: 14668431
[TBL] [Abstract][Full Text] [Related]
2. [Recessive motor neuron diseases: mutations in the ALS2 gene and molecular pathogenesis for the upper motor neurodegeneration].
Ikeda JE
Rinsho Shinkeigaku; 2004 Nov; 44(11):792-4. PubMed ID: 15651293
[TBL] [Abstract][Full Text] [Related]
3. Molecular and cellular function of ALS2/alsin: implication of membrane dynamics in neuronal development and degeneration.
Hadano S; Kunita R; Otomo A; Suzuki-Utsunomiya K; Ikeda JE
Neurochem Int; 2007; 51(2-4):74-84. PubMed ID: 17566607
[TBL] [Abstract][Full Text] [Related]
4. Novel missense mutation in ALS2 gene results in infantile ascending hereditary spastic paralysis.
Eymard-Pierre E; Yamanaka K; Haeussler M; Kress W; Gauthier-Barichard F; Combes P; Cleveland DW; Boespflug-Tanguy O
Ann Neurol; 2006 Jun; 59(6):976-80. PubMed ID: 16718699
[TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype correlation in seven motor neuron disease families with novel ALS2 mutations.
Sprute R; Jergas H; Ölmez A; Alawbathani S; Karasoy H; Dafsari HS; Becker K; Daimagüler HS; Nürnberg P; Muntoni F; Topaloglu H; Uyanik G; Cirak S
Am J Med Genet A; 2021 Feb; 185(2):344-354. PubMed ID: 33155358
[TBL] [Abstract][Full Text] [Related]
6. Infantile-onset ascending hereditary spastic paraplegia with bulbar involvement due to the novel ALS2 mutation c.2761C>T.
Wakil SM; Ramzan K; Abuthuraya R; Hagos S; Al-Dossari H; Al-Omar R; Murad H; Chedrawi A; Al-Hassnan ZN; Finsterer J; Bohlega S
Gene; 2014 Feb; 536(1):217-20. PubMed ID: 24315819
[TBL] [Abstract][Full Text] [Related]
7. Altered oligomeric states in pathogenic ALS2 variants associated with juvenile motor neuron diseases cause loss of ALS2-mediated endosomal function.
Sato K; Otomo A; Ueda MT; Hiratsuka Y; Suzuki-Utsunomiya K; Sugiyama J; Murakoshi S; Mitsui S; Ono S; Nakagawa S; Shang HF; Hadano S
J Biol Chem; 2018 Nov; 293(44):17135-17153. PubMed ID: 30224357
[TBL] [Abstract][Full Text] [Related]
8. The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function.
Panzeri C; De Palma C; Martinuzzi A; Daga A; De Polo G; Bresolin N; Miller CC; Tudor EL; Clementi E; Bassi MT
Brain; 2006 Jul; 129(Pt 7):1710-9. PubMed ID: 16670179
[TBL] [Abstract][Full Text] [Related]
9. ALS2, a novel guanine nucleotide exchange factor for the small GTPase Rab5, is implicated in endosomal dynamics.
Otomo A; Hadano S; Okada T; Mizumura H; Kunita R; Nishijima H; Showguchi-Miyata J; Yanagisawa Y; Kohiki E; Suga E; Yasuda M; Osuga H; Nishimoto T; Narumiya S; Ikeda JE
Hum Mol Genet; 2003 Jul; 12(14):1671-87. PubMed ID: 12837691
[TBL] [Abstract][Full Text] [Related]
10. Progressive spinal axonal degeneration and slowness in ALS2-deficient mice.
Yamanaka K; Miller TM; McAlonis-Downes M; Chun SJ; Cleveland DW
Ann Neurol; 2006 Jul; 60(1):95-104. PubMed ID: 16802286
[TBL] [Abstract][Full Text] [Related]
11. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2.
Hadano S; Hand CK; Osuga H; Yanagisawa Y; Otomo A; Devon RS; Miyamoto N; Showguchi-Miyata J; Okada Y; Singaraja R; Figlewicz DA; Kwiatkowski T; Hosler BA; Sagie T; Skaug J; Nasir J; Brown RH; Scherer SW; Rouleau GA; Hayden MR; Ikeda JE
Nat Genet; 2001 Oct; 29(2):166-73. PubMed ID: 11586298
[TBL] [Abstract][Full Text] [Related]
12. Single-nucleotide polymorphisms in uncoding regions of ALS2 gene of Japanese patients with autosomal-recessive amyotrophic lateral sclerosis.
Nagano I; Murakami T; Shiote M; Manabe Y; Hadano S; Yanagisawa Y; Ikeda JE; Abe K
Neurol Res; 2003 Jul; 25(5):505-9. PubMed ID: 12866199
[TBL] [Abstract][Full Text] [Related]
13. ALS2/alsin knockout mice and motor neuron diseases.
Cai H; Shim H; Lai C; Xie C; Lin X; Yang WJ; Chandran J
Neurodegener Dis; 2008; 5(6):359-66. PubMed ID: 18714162
[TBL] [Abstract][Full Text] [Related]
14. Regulation of endosomal motility and degradation by amyotrophic lateral sclerosis 2/alsin.
Lai C; Xie C; Shim H; Chandran J; Howell BW; Cai H
Mol Brain; 2009 Jul; 2():23. PubMed ID: 19630956
[TBL] [Abstract][Full Text] [Related]
15. Alsin, the product of ALS2 gene, suppresses SOD1 mutant neurotoxicity through RhoGEF domain by interacting with SOD1 mutants.
Kanekura K; Hashimoto Y; Niikura T; Aiso S; Matsuoka M; Nishimoto I
J Biol Chem; 2004 Apr; 279(18):19247-56. PubMed ID: 14970233
[TBL] [Abstract][Full Text] [Related]
16. Homo-oligomerization of ALS2 through its unique carboxyl-terminal regions is essential for the ALS2-associated Rab5 guanine nucleotide exchange activity and its regulatory function on endosome trafficking.
Kunita R; Otomo A; Mizumura H; Suzuki K; Showguchi-Miyata J; Yanagisawa Y; Hadano S; Ikeda JE
J Biol Chem; 2004 Sep; 279(37):38626-35. PubMed ID: 15247254
[TBL] [Abstract][Full Text] [Related]
17. Mutation screening of the ALS2 gene in sporadic and familial amyotrophic lateral sclerosis.
Hand CK; Devon RS; Gros-Louis F; Rochefort D; Khoris J; Meininger V; Bouchard JP; Camu W; Hayden MR; Rouleau GA
Arch Neurol; 2003 Dec; 60(12):1768-71. PubMed ID: 14676054
[TBL] [Abstract][Full Text] [Related]
18. Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene.
Eymard-Pierre E; Lesca G; Dollet S; Santorelli FM; di Capua M; Bertini E; Boespflug-Tanguy O
Am J Hum Genet; 2002 Sep; 71(3):518-27. PubMed ID: 12145748
[TBL] [Abstract][Full Text] [Related]
19. Loss of ALS2 function is insufficient to trigger motor neuron degeneration in knock-out mice but predisposes neurons to oxidative stress.
Cai H; Lin X; Xie C; Laird FM; Lai C; Wen H; Chiang HC; Shim H; Farah MH; Hoke A; Price DL; Wong PC
J Neurosci; 2005 Aug; 25(33):7567-74. PubMed ID: 16107644
[TBL] [Abstract][Full Text] [Related]
20. Amyotrophic lateral sclerosis 2-deficiency leads to neuronal degeneration in amyotrophic lateral sclerosis through altered AMPA receptor trafficking.
Lai C; Xie C; McCormack SG; Chiang HC; Michalak MK; Lin X; Chandran J; Shim H; Shimoji M; Cookson MR; Huganir RL; Rothstein JD; Price DL; Wong PC; Martin LJ; Zhu JJ; Cai H
J Neurosci; 2006 Nov; 26(45):11798-806. PubMed ID: 17093100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
